Male sex hormones dampened allergic lung inflammation in mice by strengthening nerve signals — a mechanism that may help explain why boys often outgrow asthma more than girls.
In the Phase 3 SAFFRON trial, adding Hutchmed’s Orpathys to Tagrisso delayed progression and extended overall survival in EGFR-mutated lung cancer that had developed a MET-driven resistance.
C2N Diagnostics’ PrecivityAD2 measures amyloid and tau markers from a blood draw — part of a fast-moving shift away from expensive scans and spinal taps for Alzheimer’s diagnosis.
The agency’s digital health leader says clarity is on the way — both broad guidance on generative AI and more specialized guidance for higher-risk uses.
Freenome's SimpleScreen offers a needle-in-arm alternative to stool tests and colonoscopy — but its blind spot for precancerous growths means it's no replacement for a scope.
A Cambridge study explains an obesity-drug paradox — the GIPR receptor does opposite jobs in different brain regions, so agonists and antagonists both work.
The deal adds ABS-1230, an oral drug for KCNT1-related epilepsy that has no approved treatment — Jazz’s second epilepsy acquisition in a year.
By tracking some patients for up to 25 years, Sanger Institute researchers found DNA changes that flag which slow-growing blood cancers will progress — long before symptoms.
Stanford researchers coaxed immune cells into a tumor-infiltrating form — without genetic engineering — that penetrated cancers better and, paired with an antibody drug, sharply slowed growth in mice.
The renewed alliance keeps subspecialty expertise, tumor conferences and clinical-trial access available to patients closer to home, with new local cancer services coming this autumn.
A study of a rare fat-loss disorder shows healthy fat tissue is metabolically vital — and when it becomes inflamed and disappears, diabetes can follow.
European regulators have validated the marketing application for a six-valent Lyme vaccine that showed more than 70% efficacy in a 9,437-person Phase 3 trial. No human Lyme vaccine is currently approved.